Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3610-3623

  Van Kempen, Tracey A ^a,b   Gorecka, Jolanta ^b   Gonzalez, Andreina D ^b   Soeda, Fumio ^c   Milner, Teresa A ^a,b   Waters, Elizabeth M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOHEXENE DERIVATIVE; ESTRADIOL BENZOATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN KINASE B; UNCLASSIFIED DRUG; NERVE GROWTH FACTOR;

ACCELERATED OVARIAN FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN HISTOLOGY; BRAIN REGION; CLIMACTERIUM; CONTROLLED STUDY; DENDRITIC SPINE; ELECTRON MICROSCOPY; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; EXON; EXPERIMENTAL ENDOCRINE DISEASE; FEMALE; GRANULE CELL; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; MOUSE; MOUSE MODEL; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER; NEUROTOXICITY; NONHUMAN; OVARY FOLLICLE; OVARY INSUFFICIENCY; POSTMENOPAUSE; PREMENOPAUSE; SIGNAL TRANSDUCTION; SPATIAL LEARNING; ANIMAL; DISEASE MODEL; GENETICS; HIPPOCAMPUS; HUMAN; MENOPAUSE; METABOLISM; PREMATURE OVARIAN FAILURE;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HIPPOCAMPUS; HUMANS; MENOPAUSE; MICE; NERVE GROWTH FACTORS; PRIMARY OVARIAN INSUFFICIENCY; SIGNAL TRANSDUCTION;

EID: 84907042837     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1190     Document Type: Article

References (75)

1. Sandstrom NJ, Williams CL. Spatial memory retention is enhanced by acute and continuous estradiol replacement. Horm Behav. 2004; 45:128-135.
2. Protopopescu X, Pan H, Altemus M, et al. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci USA. 2005;102:16060-16065.
3. Craig MC, Brammer M, Maki PM, et al. The interactive effect of acute ovarian suppression and the cholinergic systemonvisuospatial working memory in young women. Psychoneuroendocrinology. 2010;35:987-1000.
4. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hip-pocampal function. Front Neuroendocrinol. 2008;29:219-237.
5. Dumas JA, Kutz AM, Naylor MR, Johnson JV, Newhouse PA. Increased memory load-related frontal activation after estradiol treatment in postmenopausal women. Horm Behav. 2010;58:929-935.
6. Weber MT, Rubin LH, Maki PM. Cognition in perimenopause: the effect of transition stage. Menopause. 2013;20:511-517.
7. Van Kempen TA, Milner TA, Waters EM. Accelerated ovarian failure: a novel, chemically induced animal model of menopause. Brain Res. 2011;1379:176-187.
8. Keating AF, Fernandez SM, Mark-Kappeler CJ, Sen N, Sipes IG, Hoyer PB. Inhibition of PIK3 signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol Reprod. 2011;84:743-751.
9. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. The follicle-deplete mouse ovary produces androgen. Biol Reprod. 2004;71:130-138.
10. Lohff JC, Christian PJ, Marion SL, Hoyer PB. Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause. 2006;13:482-488.
11. Mayer LP, Pearsall NA, Christian PJ, et al. Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod Toxicol. 2002;16:775-781.
12. Lohff JC, Christian PJ, Marion SL, Arrandale A, Hoyer PB. Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comp Med. 2005;55:523-527.
13. Acosta JI, Mayer L, Talboom JS, et al. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology. 2009;150:4248-4259.
14. Acosta JI, Mayer LP, Braden BB, Nonnenmacher S, Mennenga SE, Bimonte-Nelson HA. The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical. Endocrinology. 2010;151:3795-3804.
15. Scharfman HE, Mercurio TC, Goodman JH, Wilson MA, MacLusky NJ. Hippocampal excitability increases during the es-trous cycle in the rat: a potential role for brain-derived neurotrophic factor. J Neurosci. 2003;23:11641-11652.
16. Spencer JL, Waters EM, Milner TA, McEwen BS. Estrous cycle regulates activation of hippocampal Akt, LIM kinase, and neurotro-phin receptors in C57BL/6 mice. Neuroscience. 2008;155:1106-1119.
17. Spencer-Segal JL, Waters EM, Bath KG, Chao MV, McEwen BS, Milner TA. Distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage. J Neurosci. 2011;31:6780-6790.
18. Mitterling KL, Spencer JL, Dziedzic N, et al. Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus. J Comp Neurol. 2010;518:2729-2743.
19. Li C, Brake WG, Romeo RD, et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Natl Acad Sci USA. 2004;101:2185-2190.
20. Waters EM, Yildirim M, Janssen WG, et al. Estrogen and aging affect the synaptic distribution of estrogen receptor β-immunore-activity in the CA1 region of female rat hippocampus. Brain Res. 2011;1379:86-97.
21. Spencer-Segal JL, Tsuda MC, Mattei L, et al. Estradiol acts via estrogen receptors α and β on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience. 2012;202:131-146.
22. Golub MS, Germann SL, Mercer M, et al. Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse. Neurobiol Aging. 2008;29:1512-1523.
23. Byers SL, Wiles MV, Dunn SL, Taft RA. Mouse estrous cycle identification tool and images. PLoS ONE. 2012;7:e35538.
24. Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007;80:84-97.
25. Frick KM, Fernandez SM, Bennett JC, Prange-Kiel J, MacLusky NJ, Leranth C. Behavioral training interferes with the ability of gonadal hormones to increase CA1 spine synapse density in ovariectomized female rats. Eur J Neurosci. 2004;19:3026-3032.
26. Milner TA, Waters EM, Robinson DC, Pierce JP. Degenerating processes identified by electron microscopic immunocytochemical methods. Methods Mol Biol. 2011;793:23-59.
27. Pierce JP, Kurucz OS, Milner TA. Morphometry of a peptidergic transmitter system: dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures. Hippocampus. 1999;9:255-276.
28. Peters A, Palay SL, Webster HD. The Fine Structure of the Nervous System. New York, NY: Oxford University Press; 1991.
29. McLean AC, Valenzuela N, Fai S, Bennett SAL. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012:e4389.
30. Flaws JA, Doerr JK, Sipes IG, Hoyer PB. Destruction of preantral follicles in adult rats by 4-vinyl-1-cyclohexene diepoxide. Reprod Toxicol. 1994;8:509-514.
31. Haas JR, Christian PJ, Hoyer PB. Effects of impending ovarian failure induced by 4-vinylcyclohexene diepoxide on fertility in C57BL/6 female mice. Comp Med. 2007;57:443-449.
32. Wright LE, Christian PJ, Rivera Z, et al. Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res. 2008;23:1296-1303.
33. Sahambi SK, Visser JA, Themmen AP, Mayer LP, Devine PJ. Correlation of serum anti-Müllerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice. Reprod Toxicol. 2008;26:116-122.
34. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8: 57-69.
35. Chung DW, Yoo KY, Hwang IK, et al. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell Mol Neurobiol. 2010;30:531-541.
36. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. PSD-95 involvement in maturation of excitatory synapses. Science. 2000;290:1364-1368.
37. Liu J, Bisschop PH, Eggels L, et al. Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats. Endocrinology. 2012;153:3337-3344.
38. Milner TA, McEwen BS, Hayashi S, Li CJ, Reagan LP, Alves SE. Ultrastructural evidence that hippocampal a estrogen receptors are located at extranuclear sites. J Comp Neurol. 2001;429:355-371.
39. Adams MM, Fink SE, Shah RA, et al. Estrogen and aging affect the subcellular distribution of estrogen receptor-a in the hippocampus of female rats. J Neurosci. 2002;22:3608-3614.
40. Hart SA, Snyder MA, Smejkalova T, Woolley CS. Estrogen mobilizes a subset of estrogen receptor-a-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J Neurosci. 2007;27:2102-2111.
41. Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci. 2000;20:7116-7121.
42. Scharfman HE, Maclusky NJ. Differential regulation of BDNF, synaptic plasticity and sprouting in the hippocampal mossy fiber pathway of male and female rats. Neuropharmacology. 2014;76(pt C): 696-708.
43. Sohrabji F, Miranda RC, Toran-Allerand CD. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA. 1995;92: 11110-11114.
44. Scharfman HE, Hintz TM, Gomez J, et al. Changes in hippocampal function of ovariectomized rats after sequential low doses of estradiol to simulate the preovulatory estrogen surge. Eur J Neurosci. 2007;26:2595-2612.
45. Yang L-C, Zhang Q-G, Zhou C-F, et al. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS ONE. 2010;5:e9851.
46. Zhou J, Zhang H, Cohen RS, Pandey SC. Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures. Neuroendocrinol-ogy. 2005;81:294-310.
47. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. 1998;57:1-9.
48. Luine VN, Jacome LF, Maclusky NJ. Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology. 2003;144: 2836-2844.
49. Shrivastava K, Gonzalez P, Acarin L. The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain. J Comp Neurol. 2012;520:2657-2675.
50. Keating AF, Sen N, Sipes IG, Hoyer PB. Dual protective role for glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol. 2010;247:71-75.
51. Keating AF, J Mark C, Sen N, Sipes IG, Hoyer PB. Effect of phos-phatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vi-nylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol. 2009;241:127-134.
52. Barton HA, Andersen ME, Allen BC. Dose-response characteristics of uterine responses in rats exposed to estrogen agonists. Regul Toxicol Pharmacol. 1998;28:133-149.
53. Fang ZH, Lee CH, Seo MK, et al. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res. 2013;76:187-194.
54. Donohue HS, Gabbott PL, Davies HA, et al. Chronic restraint stress induces changes in synapse morphology in stratum lacunosum-mo-leculare CA1 rat hippocampus: a stereological and three-dimensional ultrastructural study. Neuroscience. 2006;140:597-606.
55. Pierce JP, Kelter DT, McEwen BS, Waters EM, Milner TA. Hippocampal mossy fiber leu-enkephalin immunoreactivity in female rats is significantly altered following both acute and chronic stress. J Chem Neuroanat. 2014;55:9-17.
56. Van Kempen TA, Kahlid S, Gonzalez AD, et al. Sex and estrogen receptor expression influence opioid peptide levels in the mouse hippocampal mossy fiber pathway. Neurosci Lett. 2013;552:66-70.
57. Han X, Aenlle KK, Bean LA, et al. Role of estrogen receptor α and β in preserving hippocampal function during aging. J Neurosci. 2013;33:2671-2683.
58. Waters EM, Mitterling K, Spencer JL, Mazid S, McEwen BS, Milner TA. Estrogen receptor α and β specific agonists regulate expression of synaptic proteins in rat hippocampus. Brain Res. 2009;1290:1-11.
59. Phan A, Lancaster KE, Armstrong JN, MacLusky NJ, Choleris E. Rapid effects of estrogen receptor α and β selective agonists on learning and dendritic spines in female mice. Endocrinology. 2011; 152:1492-1502.
60. Yildirim M, Janssen WG, Lou WY, et al. Effects of estrogen and aging on the synaptic distribution of phosphorylated Akt-immuno-reactivity in the CA1 region of the female rat hippocampus. Brain Res. 2011;1379:98-108.
61. McEwen B, Akama K, Alves S, et al. Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA. 2001;98:7093-7100.
62. Znamensky V, Akama KT, McEwen BS, Milner TA. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci. 2003;23:2340-2347.
63. Akama KT, McEwen BS. Estrogen stimulates postsynaptic densi-ty-95 rapid protein synthesis via the Akt/protein kinase B pathway. J Neurosci. 2003;23:2333-2339.
64. Smith CC, Vedder LC, Nelson AR, Bredemann TM, McMahon LL. Duration of estrogen deprivation, not chronological age, prevents estrogen's ability to enhance hippocampal synaptic physiology. Proc Natl Acad Sci USA. 2010;107:19543-19548.
65. Zhang QG, Wang RM, Scott E, et al. Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain. 2013; 136:1432-1445.
66. Longordo F, Fan J, Steimer T, Kopp C, Lüthi A. Do mice habituate to "gentle handling?" A comparison of resting behavior, cortico-sterone levels and synaptic function in handled and undisturbed C57BL/6J mice. Sleep. 2011;34:679-681.
67. Gerlai R. Behavioral tests of hippocampal function: simple paradigms complex problems. Behav Brain Res. 2001;125:269-277.
68. Woods NF, Mitchell ES. Symptom interference with work and relationships during the menopausal transition and early postmeno-pause: observations from the Seattle Midlife Women's Health Study. Menopause. 2011;18:654-661.
69. Weber MT, Mapstone M, Staskiewicz J, Maki PM. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause. 2012;19:735-741.
70. Baker LD, Asthana S, Cholerton BA, et al. Cognitive response to estradiol in postmenopausal women is modified by high cortisol. Neurobiol Aging. 2012; 33:829. e9-e20.
71. Greendale GA, Derby CA, Maki PM. Perimenopause and cognition. Obstet Gynecol Clin North Am. 2011;38:519-535.
72. Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause. 2008;15:848-856.
73. Lambrinoudaki I, Augoulea A, Armeni E, et al. Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women. Climacteric. 2012;15:350-357.
74. Hitchcock CL, Elliott TG, Norman EG, Stajic V, Teede H, Prior JC. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women. Menopause. 2012;19:1208-1214.
75. Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci. 2013;125:311-318.